This inventor holds 1 USPTO granted patent. Top assignee: Wizbiosolutions Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hye Lim Kang: Innovator in Molecular Diagnosis Technology
Introduction
Hye Lim Kang is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of molecular diagnostics, particularly through her innovative patent. Her work focuses on enhancing the efficiency and accuracy of diagnostic processes.
Latest Patents
Hye Lim Kang holds a patent for an integrated molecular diagnosis apparatus. This apparatus includes a buffer tube designed to accommodate a sample collection tool. The buffer prepares a sample solution containing nucleic acid extracted from the collected sample. A cartridge is combined with the buffer tube, which transports the sample solution to a reaction chamber through a fluid channel. The apparatus performs a nucleic acid amplification reaction, and a diagnosis module main body is detachably combined with the cartridge. This module supplies heat at a predetermined temperature to the reaction chamber, detects the nucleic acid amplification reaction, and determines the presence of a diagnosis target.
Career Highlights
Hye Lim Kang has made strides in her career by focusing on innovative solutions in the medical technology sector. Her patent reflects her commitment to improving diagnostic methods, which can have a profound impact on patient care and treatment outcomes.
Collaborations
Hye Lim Kang collaborates with talented individuals such as Sang Gyu Cho and Jeong Hun Cheon. These partnerships enhance her research and development efforts, contributing to the advancement of molecular diagnostics.
Conclusion
Hye Lim Kang is a pioneering inventor whose work in molecular diagnosis technology is shaping the future of healthcare. Her innovative patent demonstrates her dedication to improving diagnostic processes, ultimately benefiting patients and medical professionals alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile